• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
MRI features predict survival and molecular markers in diffuse lower-grade gliomas.磁共振成像特征可预测弥漫性低级别胶质瘤的生存率及分子标志物。
Neuro Oncol. 2017 Jun 1;19(6):862-870. doi: 10.1093/neuonc/now256.
2
Prediction of -Mutation and 1p/19q-Codeletion Status Using Preoperative MR Imaging Phenotypes in Lower Grade Gliomas.术前磁共振成像表型预测低级别胶质瘤中的 -突变和 1p/19q 缺失状态。
AJNR Am J Neuroradiol. 2018 Jan;39(1):37-42. doi: 10.3174/ajnr.A5421. Epub 2017 Nov 9.
3
Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomas.异柠檬酸脱氢酶(IDH)突变、1p/19q 缺失及磷酸酶和张力蛋白同源物(PTEN)缺失分析可明确临床低级别弥漫性胶质瘤的预后。
Neuro Oncol. 2014 Jul;16(7):914-23. doi: 10.1093/neuonc/not299.
4
TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations.TERT 启动子突变与 1p/19q 状态无关,对 IDH1/2 突变的成人弥漫性胶质瘤具有有利的预后。
Acta Neuropathol Commun. 2020 Nov 23;8(1):201. doi: 10.1186/s40478-020-01078-2.
5
Whole-Tumor Histogram and Texture Analyses of DTI for Evaluation of -Mutation and 1p/19q-Codeletion Status in World Health Organization Grade II Gliomas.弥散张量成像全肿瘤直方图和纹理分析评估世界卫生组织 II 级胶质瘤的 - 突变和 1p/19q 缺失状态。
AJNR Am J Neuroradiol. 2018 Apr;39(4):693-698. doi: 10.3174/ajnr.A5569. Epub 2018 Mar 8.
6
Impact of 1p/19q codeletion status on extent of resection in WHO grade II glioma: Insights from a national cancer registry.1p/19q共缺失状态对世界卫生组织II级胶质瘤切除范围的影响:来自国家癌症登记处的见解
Clin Neurol Neurosurg. 2019 Jul;182:32-36. doi: 10.1016/j.clineuro.2019.04.027. Epub 2019 Apr 30.
7
The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.T2-FLAIR 错配征象作为弥漫性低级别胶质瘤 IDH 和 1p/19q 状态的影像学生物标志物:一项基于贝叶斯方法评估诊断试验性能的系统评价。
Neurosurg Focus. 2019 Dec 1;47(6):E13. doi: 10.3171/2019.9.FOCUS19660.
8
Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.IDH 1/2 突变且无 1p/19q 共缺失的 WHO Ⅲ级胶质瘤患者行全切除的影响
J Neurooncol. 2016 Sep;129(3):505-514. doi: 10.1007/s11060-016-2201-2. Epub 2016 Jul 11.
9
IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.世界卫生组织二级胶质瘤中的异柠檬酸脱氢酶(IDH)突变、1p19q共缺失和α-地中海贫血/智力发育障碍综合征X连锁基因(ATRX)缺失
Oncotarget. 2015 Oct 6;6(30):30295-305. doi: 10.18632/oncotarget.4497.
10
1p/19q codeletion and IDH1/2 mutation identified a subtype of anaplastic oligoastrocytomas with prognosis as favorable as anaplastic oligodendrogliomas.1p/19q 号染色体缺失和 IDH1/2 突变确定了具有与间变性少突胶质细胞瘤一样良好预后的间变性少突星形细胞瘤亚型。
Neuro Oncol. 2013 Jun;15(6):775-82. doi: 10.1093/neuonc/not027. Epub 2013 Mar 13.

引用本文的文献

1
Phenotype augmentation using generative AI for isocitrate dehydrogenase mutation prediction in glioma.使用生成式人工智能进行胶质瘤异柠檬酸脱氢酶突变预测的表型增强。
Sci Rep. 2025 Aug 7;15(1):28913. doi: 10.1038/s41598-025-14477-z.
2
Hybrid classical and quantum computing for enhanced glioma tumor classification using TCGA data.利用TCGA数据的混合经典与量子计算用于增强胶质瘤肿瘤分类
Sci Rep. 2025 Jul 17;15(1):25935. doi: 10.1038/s41598-025-97067-3.
3
Multimodal MRI radiomics based on habitat subregions of the tumor microenvironment for predicting risk stratification in glioblastoma.基于肿瘤微环境栖息地亚区域的多模态MRI放射组学用于预测胶质母细胞瘤的风险分层
PLoS One. 2025 Jun 27;20(6):e0326361. doi: 10.1371/journal.pone.0326361. eCollection 2025.
4
Integration of MRI radiomics and germline genetics to predict the IDH mutation status of gliomas.整合MRI影像组学与种系遗传学以预测胶质瘤的异柠檬酸脱氢酶(IDH)突变状态
NPJ Precis Oncol. 2025 Jun 16;9(1):187. doi: 10.1038/s41698-025-00980-z.
5
MRI features and prognostic evaluation in patients with subventricular zone-contacting IDH-wild-type glioblastoma.脑室下区接触性异柠檬酸脱氢酶野生型胶质母细胞瘤患者的MRI特征及预后评估
Radiol Oncol. 2025 May 30;59(2):1-8. doi: 10.2478/raon-2025-0029. eCollection 2025 Jun 1.
6
Enhanced magnetic resonance imaging-based radiomics predicts CD40LG expression and survival in high-grade gliomas: a retrospective study.基于增强磁共振成像的影像组学预测高级别胶质瘤中CD40LG的表达及生存情况:一项回顾性研究
Discov Oncol. 2025 May 30;16(1):962. doi: 10.1007/s12672-025-02721-x.
7
Systematic review and epistemic meta-analysis to advance binomial AI-radiomics integration for predicting high-grade glioma progression and enhancing patient management.系统评价与认知元分析,以推进二项式人工智能-放射组学整合,用于预测高级别胶质瘤进展并改善患者管理。
Sci Rep. 2025 May 8;15(1):16113. doi: 10.1038/s41598-025-98058-0.
8
From pixels to prognosis: leveraging radiomics and machine learning to predict IDH1 genotype in gliomas.从像素到预后:利用影像组学和机器学习预测胶质瘤中的异柠檬酸脱氢酶1(IDH1)基因型
Neurosurg Rev. 2025 Apr 29;48(1):396. doi: 10.1007/s10143-025-03515-z.
9
Synthetic O-(2-F-fluoroethyl)-l-tyrosine-positron emission tomography generation and hotspot prediction via preoperative MRI fusion of gliomas lacking radiographic high-grade characteristics.通过缺乏影像学高级别特征的胶质瘤术前MRI融合进行合成O-(2-F-氟乙基)-L-酪氨酸正电子发射断层扫描生成及热点预测。
Neurooncol Adv. 2025 Jan 16;7(1):vdaf001. doi: 10.1093/noajnl/vdaf001. eCollection 2025 Jan-Dec.
10
Preoperative MR - based model for predicting prognosis in patients with intracranial extraventricular ependymoma.基于术前磁共振成像的模型预测颅内室管膜外瘤患者的预后
Eur J Radiol Open. 2025 Apr 8;14:100650. doi: 10.1016/j.ejro.2025.100650. eCollection 2025 Jun.

本文引用的文献

1
Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas.多模态磁共振成像特征可预测高级别胶质瘤中的异柠檬酸脱氢酶基因型。
Neuro Oncol. 2017 Jan;19(1):109-117. doi: 10.1093/neuonc/now121. Epub 2016 Jun 26.
2
Imaging genomics in cancer research: limitations and promises.癌症研究中的影像基因组学:局限与前景
Br J Radiol. 2016;89(1061):20151030. doi: 10.1259/bjr.20151030. Epub 2016 Feb 11.
3
Evaluation of tumor-derived MRI-texture features for discrimination of molecular subtypes and prediction of 12-month survival status in glioblastoma.评估肿瘤衍生的MRI纹理特征以鉴别胶质母细胞瘤的分子亚型并预测其12个月生存状态
Med Phys. 2015 Nov;42(11):6725-35. doi: 10.1118/1.4934373.
4
Texture Feature Ratios from Relative CBV Maps of Perfusion MRI Are Associated with Patient Survival in Glioblastoma.灌注MRI相对脑血容量图的纹理特征比率与胶质母细胞瘤患者的生存率相关。
AJNR Am J Neuroradiol. 2016 Jan;37(1):37-43. doi: 10.3174/ajnr.A4534. Epub 2015 Oct 15.
5
A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities.一种基于联合FDG-PET与MRI纹理特征的放射组学模型,用于预测四肢软组织肉瘤的肺转移。
Phys Med Biol. 2015 Jul 21;60(14):5471-96. doi: 10.1088/0031-9155/60/14/5471. Epub 2015 Jun 29.
6
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.弥漫性低级别胶质瘤的综合、整合基因组分析
N Engl J Med. 2015 Jun 25;372(26):2481-98. doi: 10.1056/NEJMoa1402121. Epub 2015 Jun 10.
7
Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients.磁共振成像特征和基因生物标志物的加入增强了TCGA患者中胶质母细胞瘤生存预测能力。
J Neuroradiol. 2015 Jul;42(4):212-21. doi: 10.1016/j.neurad.2014.02.006. Epub 2014 Jul 2.
8
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.采用定量放射组学方法通过无创成像解码肿瘤表型。
Nat Commun. 2014 Jun 3;5:4006. doi: 10.1038/ncomms5006.
9
Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.多形性胶质母细胞瘤:利用定量图像特征进行的探索性放射基因组分析
Radiology. 2014 Oct;273(1):168-74. doi: 10.1148/radiol.14131731. Epub 2014 May 12.
10
Relationship between tumor heterogeneity measured on FDG-PET/CT and pathological prognostic factors in invasive breast cancer.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)所测量的肿瘤异质性与浸润性乳腺癌病理预后因素之间的关系
PLoS One. 2014 Apr 10;9(4):e94017. doi: 10.1371/journal.pone.0094017. eCollection 2014.

磁共振成像特征可预测弥漫性低级别胶质瘤的生存率及分子标志物。

MRI features predict survival and molecular markers in diffuse lower-grade gliomas.

作者信息

Zhou Hao, Vallières Martin, Bai Harrison X, Su Chang, Tang Haiyun, Oldridge Derek, Zhang Zishu, Xiao Bo, Liao Weihua, Tao Yongguang, Zhou Jianhua, Zhang Paul, Yang Li

机构信息

Department of Neurology, First Xiangya Hospital, Central South University, Changsha, Hunan, China

Department of Neurology, Second Xiangya Hospital, Central South University, Changsha, Hunan, China

出版信息

Neuro Oncol. 2017 Jun 1;19(6):862-870. doi: 10.1093/neuonc/now256.

DOI:10.1093/neuonc/now256
PMID:28339588
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5464433/
Abstract

BACKGROUND

Previous studies have shown that MR imaging features can be used to predict survival and molecular profile of glioblastoma. However, no study of a similar type has been performed on lower-grade gliomas (LGGs).

METHODS

Presurgical MRIs of 165 patients with diffuse low- and intermediate-grade gliomas (histological grades II and III) were scored according to the Visually Accessible Rembrandt Images (VASARI) annotations. Radiomic models using automated texture analysis and VASARI features were built to predict isocitrate dehydrogenase 1 (IDH1) mutation, 1p/19q codeletion status, histological grade, and tumor progression.

RESULTS

Interrater analysis showed significant agreement in all imaging features scored (k = 0.703-1.000). On multivariate Cox regression analysis, no enhancement and a smooth non-enhancing margin were associated with longer progression-free survival (PFS), while a smooth non-enhancing margin was associated with longer overall survival (OS) after taking into account age, grade, tumor location, histology, extent of resection, and IDH1 1p/19q subtype. Using logistic regression and bootstrap testing evaluations, texture models were found to possess higher prediction potential for IDH1 mutation, 1p/19q codeletion status, histological grade, and progression of LGGs than VASARI features, with areas under the receiver-operating characteristic curves of 0.86 ± 0.01, 0.96 ± 0.01, 0.86 ± 0.01, and 0.80 ± 0.01, respectively.

CONCLUSION

No enhancement and a smooth non-enhancing margin on MRI were predictive of longer PFS, while a smooth non-enhancing margin was a significant predictor of longer OS in LGGs. Textural analyses of MR imaging data predicted IDH1 mutation, 1p/19q codeletion, histological grade, and tumor progression with high accuracy.

摘要

背景

既往研究表明,磁共振成像(MR)特征可用于预测胶质母细胞瘤的生存期和分子特征。然而,尚未对低级别胶质瘤(LGG)进行类似的研究。

方法

根据可视化可及性伦勃朗图像(VASARI)注释,对165例弥漫性低级别和中级别的胶质瘤(组织学分级为II级和III级)患者的术前MRI进行评分。利用自动纹理分析和VASARI特征构建放射组学模型,以预测异柠檬酸脱氢酶1(IDH1)突变、1p/19q共缺失状态、组织学分级和肿瘤进展。

结果

评分者间分析显示,所有评分的影像特征均具有显著一致性(k = 0.703 - 1.000)。多因素Cox回归分析显示,无强化和光滑的无强化边缘与更长的无进展生存期(PFS)相关,而在考虑年龄、分级、肿瘤位置、组织学、切除范围和IDH1 1p/19q亚型后,光滑的无强化边缘与更长的总生存期(OS)相关。通过逻辑回归和自助检验评估发现,与VASARI特征相比,纹理模型对LGG的IDH1突变、1p/19q共缺失状态、组织学分级和进展具有更高的预测潜力,受试者操作特征曲线下面积分别为0.86±0.01、0.96±0.01、0.86±0.01和0.80±0.01。

结论

MRI上无强化和光滑的无强化边缘可预测LGG患者更长的PFS,而光滑的无强化边缘是LGG患者更长OS的重要预测指标。MR成像数据的纹理分析可高精度预测IDH1突变、1p/19q共缺失、组织学分级和肿瘤进展。